Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
EuroEyes International Eye Clinic Limited ( (HK:1846) ) has issued an announcement.
EuroEyes International Eye Clinic Limited has announced a series of changes in its executive management and board composition. Dr. Markus Braun has resigned as Executive Director and CFO, effective September 2025, to pursue personal career development. He will be succeeded by Mr. Marcus Huascar Bracklo, who has been re-designated from a non-executive to an executive director and appointed as the new CFO. Mr. Bracklo brings over 25 years of experience in the healthcare sector, specializing in corporate finance and mergers and acquisitions, which is expected to positively impact the company’s strategic and financial development.
The most recent analyst rating on (HK:1846) stock is a Hold with a HK$3.50 price target. To see the full list of analyst forecasts on EuroEyes International Eye Clinic Limited stock, see the HK:1846 Stock Forecast page.
More about EuroEyes International Eye Clinic Limited
EuroEyes International Eye Clinic Limited operates in the healthcare industry, focusing on providing eye care services. The company specializes in refractive surgery and other eye-related medical procedures, with a market focus on delivering advanced eye care solutions.
Average Trading Volume: 150,891
Technical Sentiment Signal: Hold
Current Market Cap: HK$1.06B
See more insights into 1846 stock on TipRanks’ Stock Analysis page.